Aclarion, Inc. (ACON) is a publicly traded company in the Healthcare — Medical - Healthcare Information Services industry listed on NASDAQ. This overview shows the latest price, key valuation ratios, profitability metrics and financial-health indicators used by fundamental investors.
Aclarion, Inc., a healthcare technology enterprise based in San Mateo, California, was founded in 2008 and operates within the United States. The company specializes in creating software for magnetic resonance spectroscopy (MRS) applications.
Price
| Price | $2.55 |
| Market Cap | $1M |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | 0.37 |
| EV / EBITDA | 1.68 |
| Dividend Yield | 0.00% |
Profitability
| Return on Equity | -59.34% |
| Return on Invested Capital | -57.11% |
| Return on Assets | -50.98% |
| Gross Margin | -50.96% |
| Operating Margin | -11592.14% |
| Net Margin | -10978.48% |
Financial Health
| Debt / Equity | 0.00 |
| Current Ratio | 16.20 |
| Piotroski F-Score | 3 |
| Altman Z-Score | -4.92 |
What to look at in Healthcare / Pharma
The R&D pipeline is the invisible asset. Patents expiring = revenues evaporating. Look at innovation and cash flow.
- R&D / Revenue — Shows investment in future pipeline. Serious pharma reinvests 15-20%
- 5y EPS growth — After patent expirations, are they still growing?
- Gross margin — Branded pharma >70%. Generics much lower — defines the business type
- FCF / Net Income — Earnings quality — big pharma should convert >90%
- ROIC — Capital reinvested efficiently — key in pharma due to long R&D cycles
- Net debt / EBITDA — Pharma acquisitions pile up debt — watch the post-M&A picture
- P/E vs own 10y history — The best comparison is with its own history, not with peers
Peer Comparison
| Symbol | Company | Market Cap | P/E | P/B | ROE |
|---|---|---|---|---|---|
| ACON | Aclarion, Inc. | $1M | 0.37 | -59.3% | |
| TEM | Tempus AI, Inc. | $12.3B | 22.79 | -49.9% | |
| BTSG | BrightSpring Health Services, Inc. Common Stock | $11.6B | |||
| HQY | HealthEquity, Inc. | $8.1B | 34.54 | 4.05 | |
| HNGE | Hinge Health, Inc. | $7.3B | |||
| WAY | Waystar Holding Corp. | $5.1B | 34.57 | 1.20 | 3.6% |
| DOCS | Doximity, Inc. | $4.8B | 29.31 | 5.20 | |
| HTFL | Heartflow, Inc. Common Stock | $4.2B | 14.82 | -42.3% |
Explore sector: Healthcare · Medical - Healthcare Information Services
More sections of ACON: Financials · Valuation · Statistics · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks